Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation

被引:80
作者
Riordan, RD [1 ]
Khonsari, M [1 ]
Jeffries, J [1 ]
Maskell, GF [1 ]
Cook, PG [1 ]
机构
[1] Royal Cornwall Hosp, Dept Radiol, Truro TR1 3LJ, Cornwall, England
关键词
D O I
10.1259/bjr/36674326
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The quality of magnetic resonance cholangiopancreatography (MRCP) images is frequently degraded by high signal from the gastrointestinal tract. The aim of this study is to evaluate pineapple juice (PJ) as an oral negative contrast agent in MRCP. Preliminary in vitro evaluation demonstrated that PJ shortened T-2 relaxation time and hence decreased T2 signal intensity on a standard MRCP sequence to a similar degree to a commercially available negative contrast agent (ferumoxsil). Electrothermal atomic absorption spectrometry assay demonstrated a high manganese concentration in PJ of 2.76 mg dl(-1), which is likely to be responsible for its T-2 imaging properties. MRCP was subsequently performed in 10 healthy volunteers, before and at 15 min and 30 min following ingestion of 400 ml of PJ. Images were assessed blindly by two Consultant Radiologists using a standard grading technique based on contrast effect (degree of suppression of bowel signal), and image effect (diagnostic quality). There were statistically significant improvements in contrast and image effect between pre and post PJ images. There was particularly significant improvement in visualization of the pancreatic duct, but no significant difference between 15 min and 30 min post PJ images. Visualization of the ampulla, common bile duct, common hepatic and central intrahepatic ducts were also significantly improved at 15 min following PJ. Our results demonstrate that PJ, may be used as an alternative to commercially available negative oral contrast agent in MRCP.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 23 条
  • [1] Tasty, cost-effective and healthy: Abdominal MRI in patients with IBD with a new oral contrast agent.
    Albrich, H
    Herfarth, HH
    Schreyer, AG
    Andus, T
    Schoelmerich, J
    Feuerbach, S
    Geissler, A
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1077 - A1077
  • [2] Blandino A, 1998, Radiol Med, V96, P87
  • [3] Calvo MM, 2002, AM J GASTROENTEROL, V97, P347
  • [4] RLSQ - T1, T2, AND RHO-CALCULATIONS, COMBINING RATIOS AND LEAST-SQUARES
    DENKLEEF, JJEI
    CUPPEN, JJM
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1987, 5 (06) : 513 - 524
  • [5] DINESH L, 2003, NZ MED J, V116, pU496
  • [6] Freeman Martin L, 2002, Rev Gastroenterol Disord, V2, P147
  • [7] Pitfalls of MR cholangiopancreatography (MRCP)
    Fulcher, AS
    Turner, MA
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1998, 22 (06) : 845 - 850
  • [8] Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP)
    Hintze, RE
    Adler, A
    Veltzke, W
    AbouRebyeh, H
    Hammerstingl, R
    Vogl, T
    Felix, R
    [J]. ENDOSCOPY, 1997, 29 (03) : 182 - 187
  • [9] BLUEBERRY JUICE - PRELIMINARY EVALUATION AS AN ORAL CONTRAST AGENT IN GASTROINTESTINAL MR-IMAGING
    HIRAISHI, K
    NARABAYASHI, I
    FUJITA, O
    YAMAMOTO, K
    SAGAMI, A
    HISADA, Y
    SAIKA, Y
    ADACHI, I
    HASEGAWA, H
    [J]. RADIOLOGY, 1995, 194 (01) : 119 - 123
  • [10] MR cholangiopancreatography and MR urography: Improved enhancement with a negative oral contrast agent
    Hirohashi, S
    Hirohashi, R
    Uchida, H
    Kitano, S
    Ono, W
    Ohnishi, H
    Nakanishi, S
    [J]. RADIOLOGY, 1997, 203 (01) : 281 - 285